IN2014KN01374A - - Google Patents

Info

Publication number
IN2014KN01374A
IN2014KN01374A IN1374KON2014A IN2014KN01374A IN 2014KN01374 A IN2014KN01374 A IN 2014KN01374A IN 1374KON2014 A IN1374KON2014 A IN 1374KON2014A IN 2014KN01374 A IN2014KN01374 A IN 2014KN01374A
Authority
IN
India
Prior art keywords
resistance
cells
identification
generation
cell cultures
Prior art date
Application number
Other languages
English (en)
Inventor
Ulrich Elling
Josef Penninger
Jasmin Taubenschmid
Original Assignee
Imba Inst Für Molekulare Biotechnologie Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imba Inst Für Molekulare Biotechnologie Gmbh filed Critical Imba Inst Für Molekulare Biotechnologie Gmbh
Publication of IN2014KN01374A publication Critical patent/IN2014KN01374A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0603Embryonic cells ; Embryoid bodies
    • C12N5/0606Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/025Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/686Polymerase chain reaction [PCR]
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5014Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing toxicity
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00Use of cells in diagnostics
    • C12N2503/02Drug screening
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/106Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • General Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pathology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Food Science & Technology (AREA)
  • Public Health (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Oncology (AREA)
IN1374KON2014 2011-11-30 2012-11-30 IN2014KN01374A (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP11191408.1A EP2599859A1 (fr) 2011-11-30 2011-11-30 Cellules haploïdes
US201161565626P 2011-12-01 2011-12-01
PCT/EP2012/074112 WO2013079670A1 (fr) 2011-11-30 2012-11-30 Cellules haploïdes

Publications (1)

Publication Number Publication Date
IN2014KN01374A true IN2014KN01374A (fr) 2015-10-16

Family

ID=45218335

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1374KON2014 IN2014KN01374A (fr) 2011-11-30 2012-11-30

Country Status (11)

Country Link
US (1) US20140342369A1 (fr)
EP (2) EP2599859A1 (fr)
JP (1) JP2015500637A (fr)
KR (1) KR20140101390A (fr)
CN (1) CN104024404A (fr)
AU (1) AU2012343826A1 (fr)
CA (1) CA2856810A1 (fr)
IL (1) IL232879A0 (fr)
IN (1) IN2014KN01374A (fr)
SG (1) SG11201402350QA (fr)
WO (1) WO2013079670A1 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2629285T5 (es) 2011-03-02 2020-07-23 Anton Wutz Células madre embrionarias haploides de mamífero
WO2015152146A1 (fr) * 2014-03-31 2015-10-08 国立大学法人東京医科歯科大学 Procédé de culture de cellules souches embryonnaires haploïdes
CA2993476A1 (fr) 2015-07-29 2017-02-02 New York Stem Cell Foundation, Inc. Lignees de cellules souches embryonnaires humaines haploides et lignees de cellules somatiques humaines haploides et procedes de production de celles-ci
US11859232B2 (en) 2016-06-19 2024-01-02 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Screening for chemotherapy resistance in human haploid cells
US11608570B2 (en) 2016-07-29 2023-03-21 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Targeted in situ protein diversification by site directed DNA cleavage and repair
EP3388530A1 (fr) 2017-04-13 2018-10-17 IMBA-Institut für Molekulare Biotechnologie GmbH Modification et procédé d'identification d'acide nucléique
CA3058540A1 (fr) 2017-04-13 2018-10-18 Imba - Institut Fur Molekulare Biotechnologie Gmbh Modification d'acide nucleique et procede d'identification
CN108998410B (zh) * 2017-06-07 2020-11-06 中国科学院动物研究所 蛋白激酶抑制剂在抑制单倍体细胞二倍化中的用途
CN107217042B (zh) * 2017-07-31 2020-03-06 江苏东抗生物医药科技有限公司 一种生产无岩藻糖基化蛋白的基因工程细胞系及其建立方法
US10626319B1 (en) 2019-05-17 2020-04-21 King Fahd University Of Petroleum And Minerals Methods of inhibiting corrosion with a pyrazine corrosion inhibitor

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5945577A (en) 1997-01-10 1999-08-31 University Of Massachusetts As Represented By Its Amherst Campus Cloning using donor nuclei from proliferating somatic cells
EP1092768A1 (fr) 1999-10-16 2001-04-18 ARTEMIS Pharmaceuticals GmbH Construction pour le piègeage conditionel et la disruption de gènes
AU782846B2 (en) 1999-10-28 2005-09-01 University Of Massachusetts Gynogenetic or androgenetic production of pluripotent cells and cell lines, and use thereof to produce differentiated cells and tissues
CA2388510A1 (fr) 1999-11-02 2001-05-10 James M. Robl Utilisation de genomes haploides a des fins genetiques de diagnostic, de modification et de multiplication
US7074611B2 (en) 2001-04-27 2006-07-11 Gie-Cerbn, Centre Europeen De Recherche En Biologie Et En Medecine (Gie) Method for the stable inversion of DNA sequence by site-specific recombination and DNA vectors and transgenic cells thereof
US7235654B2 (en) 2002-12-09 2007-06-26 Boehringer Ingelheim Pharmaceuticals, Inc. Methods for modulating IKKα activity
DK2457999T3 (en) 2002-12-16 2019-02-11 Technion Res & Dev Foundation CULTIVATION MEDIUM FOR PLURIPOTENT STEM CELLS
EP1662005A1 (fr) 2004-11-26 2006-05-31 FrankGen Biotechnologie AG Vecteurs pièges contenant au moins un enhancer et adéquats pour un "gene trapping" aléatoire ou ciblé
DK1815001T3 (da) 2004-11-26 2011-05-16 Helmholtz Zentrum Muenchen Genfældekassetter til tilfældig og målrettet konditioneret geninaktivering
US20100069251A1 (en) 2006-09-15 2010-03-18 Children's Medical Center Corporation Methods for producing embryonic stem cells from parthenogenetic embryos
US20080299091A1 (en) * 2007-04-06 2008-12-04 International Stem Cell Corporation Patient-specific stem cell lines derived from human parthenogenetic blastocysts
ES2629285T5 (es) * 2011-03-02 2020-07-23 Anton Wutz Células madre embrionarias haploides de mamífero

Also Published As

Publication number Publication date
JP2015500637A (ja) 2015-01-08
EP2785832A1 (fr) 2014-10-08
AU2012343826A1 (en) 2014-06-12
CA2856810A1 (fr) 2013-06-06
IL232879A0 (en) 2014-07-31
EP2599859A1 (fr) 2013-06-05
US20140342369A1 (en) 2014-11-20
SG11201402350QA (en) 2014-06-27
KR20140101390A (ko) 2014-08-19
CN104024404A (zh) 2014-09-03
WO2013079670A1 (fr) 2013-06-06

Similar Documents

Publication Publication Date Title
IN2014KN01374A (fr)
MY183741A (en) Methods and compositions for increasing efficiency of targeted gene modification using oligonucleotide-mediated gene repair
NZ627373A (en) Genes involved in noscapine production
MX2014012994A (es) Direccion transmitida por nucleasa con vectores de direccion grandes.
IL252045B (en) Isolated nucleic acid, expression vector and cell culture comprising the nucleic acid
EA024121B9 (ru) Композиции эндорибонуклеаз и способы их использования
MX2019010226A (es) Composiciones de nanoparticulas lipidicas y metodos para administracion de arnm.
EP2545182A4 (fr) Molécules polynucléotidiques pour régulation génique dans les végétaux
SG10201809901SA (en) Generating Pluripotent Cells De Novo
HK1188466A1 (en) Plant derived cell culture material
NZ628549A (en) Novel class of glyphosate resistance genes
PH12015500213A1 (en) Production of fmdv-resistant livestock by allele substitution
MX2011011508A (es) Vector genico.
IN2014DN10996A (fr)
MX2023003672A (es) Composiciones y metodos para inhibir la expresion del gen de alfa-1 antitripsina.
MX2013007689A (es) Moleculas de acido nucleico que confieren resistencia a pestes de coleopteran.
ZA201202814B (en) Engineered zinc finger proteins targeting plant genes involved in fatty acid biosynthesis
MX356625B (es) Oligonucleotidos para elaborar un cambio en la secuencia de una molécula de ácido ribonucleico objetivo presente en una célula viva.
MX2014000301A (es) Métodos para mejorar el rendimiento y la tolerancia al estrés es una planta.
WO2012142116A3 (fr) Identification et utilisation de mutants de krp dans le blé
IN2015KN00073A (fr)
MY191390A (en) Methods and compositions for increasing efficiency of increased efficiency of targeted gene modification using oligonucleotide-mediated gene repair
MX368901B (es) Interferencia de la represion del factor de transcripcion hd-zip de expresion genica para la produccion de plantas con rasgos mejorados.
EP2707479A4 (fr) Utilisation de zscan4 et gènes dépendant de zscan4 pour reprogrammation directe de cellules somatiques
IN2012DN01604A (fr)